Quarterly Report II 20/21

Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2020 – February 28, 2021 · Net result: MSEK 120.0 (30.3), second quarter 15.1 (37.1). The increase compared to previous year is a one-off effect of corresponding MSEK 144.4 due to profit from divestment of shares in Companion Medical, Inc. · Result per share: SEK 1.7 (0.4), second quarter SEK 0.2 (0.5) · Cash flow from